Zacks Investment Research Given this performance so far, should investors still consider holding on to Cigna stock, or should they steer clear of it? Let’s delve deeper. Cigna and the broader ...

The subdued stock price reaction suggests that The Cigna Group's (NYSE:CI) strong earnings didn't offer any surprises. Our analysis suggests that investors might be missing some promising details.

In the latest market close, Cigna (CI) reached $292.07 ... in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a ...

The stock trailed the S&P 500 ... Analysts and investors alike will be keeping a close eye on the performance of Cigna in its upcoming earnings disclosure. The company's earnings report is ...

Wall Street analysts forecast that Cigna (CI) will report quarterly ... estimate revision and the short-term price performance of a stock. While investors usually depend on consensus earnings ...

Cigna rebounded after the health insurance giant abandoned a potential cash-and-stock acquisition of Humana. Instead, the company will focus on smaller bolt-on acquisitions and "value-enhancing ...

Following the earnings announcement, Cigna’s stock price rose by 2.4%, reflecting investor confidence in the company’s financial health and future prospects. The stock’s performance remains ...

Shares of Cigna slipped after The Wall Street Journal reported that the insurance giant was near a deal to sell its Medicare business. Cigna's shares were recently down more than 1%. Read more ...

Cigna ((CI)) has held its Q1 earnings call. Read on for the main highlights of the call. Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter. Receive undervalued ...